Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Spruit, Marco R"'
In this resource paper we release ChiSCor, a new corpus containing 619 fantasy stories, told freely by 442 Dutch children aged 4-12. ChiSCor was compiled for studying how children render character perspectives, and unravelling language and cognition
Externí odkaz:
http://arxiv.org/abs/2310.20328
Autor:
van Duijn, Max J., van Dijk, Bram M. A., Kouwenhoven, Tom, de Valk, Werner, Spruit, Marco R., van der Putten, Peter
To what degree should we ascribe cognitive capacities to Large Language Models (LLMs), such as the ability to reason about intentions and beliefs known as Theory of Mind (ToM)? Here we add to this emerging debate by (i) testing 11 base- and instructi
Externí odkaz:
http://arxiv.org/abs/2310.20320
Current Large Language Models (LLMs) are unparalleled in their ability to generate grammatically correct, fluent text. LLMs are appearing rapidly, and debates on LLM capacities have taken off, but reflection is lagging behind. Thus, in this position
Externí odkaz:
http://arxiv.org/abs/2310.19671
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tawfik, Noha S., Spruit, Marco R.
Publikováno v:
In Journal of Biomedical Informatics April 2020 104
Autor:
Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eugène P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Sub Natural Language Processing, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Drugs & Aging
Drugs and Aging, 39, 59-73. ADIS INT LTD
Sallevelt, Bastiaan T G M; Huibers, Corlina J A; Heij, Jody M J Op; Egberts, Toine C G; van Puijenbroek, Eugène P; Shen, Zhengru; Spruit, Marco R; Jungo, Katharina Tabea; Rodondi, Nicolas; Dalleur, Olivia; Spinewine, Anne; Jennings, Emma; O'Mahony, Denis; Wilting, Ingeborg; Knol, Wilma (2022). Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs & aging, 39(1), pp. 59-73. Adis International 10.1007/s40266-021-00904-z
Drugs & Aging, 39(1), 59-73. ADIS INT LTD
Drugs & Aging, 39(1), 59. NLM (Medline)
Drugs and Aging, 39, 59-73. ADIS INT LTD
Sallevelt, Bastiaan T G M; Huibers, Corlina J A; Heij, Jody M J Op; Egberts, Toine C G; van Puijenbroek, Eugène P; Shen, Zhengru; Spruit, Marco R; Jungo, Katharina Tabea; Rodondi, Nicolas; Dalleur, Olivia; Spinewine, Anne; Jennings, Emma; O'Mahony, Denis; Wilting, Ingeborg; Knol, Wilma (2022). Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs & aging, 39(1), pp. 59-73. Adis International 10.1007/s40266-021-00904-z
Drugs & Aging, 39(1), 59-73. ADIS INT LTD
Drugs & Aging, 39(1), 59. NLM (Medline)
Background The Screening Tool of Older Persons’ Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate the appropriateness of medication in older people. STOPP/START criteria have been converted into
Publikováno v:
In Procedia Technology 2012 5:696-705
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tawfik, Noha S1 (AUTHOR) noha.abdelsalam@aast.edu, Spruit, Marco R2 (AUTHOR)
Publikováno v:
Database: The Journal of Biological Databases & Curation. 2018, Vol. 2018, p1-N.PAG. 9p.
Autor:
Felix, Susanne E A, Bagheri, Ayoub, Ramjankhan, Faiz R, Spruit, Marco R, Oberski, Daniel, De Jonge, Nicolaas, Van Laake, Linda W, Suyker, Willem J L, Asselbergs, Folkert W, Leerstoel Oberski, Methodology and statistics for the behavioural and social sciences, Sub Natural Language Processing
Publikováno v:
European Heart Journal-Digital Health, 2(4), 635
AimsOver a third of patients, treated with mechanical circulatory support (MCS) for end-stage heart failure, experience major bleeding. Currently, the prediction of a major bleeding in the near future is difficult because of many contributing factors